Multiple myeloma develops in 6.1 per 100,000 people per year. With conventional treatment, median survival is 3-4 years, which may be extended to 5-7 years or longer with advanced treatments. The five year survival rate is 45%.In the United States in 2014, there will be an estimated 24,050 new cases and 11,090 deaths.